Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
ConclusionBased on the comprehensive analytical similarity assessment, ABP 980 is analytically highly similar to the reference product, trastuzumab.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research